Search research articles

Related Concept Videos

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Home
Genetic Assessment Of Intraductal Papillary Mucinous Neoplasm For Predicting Concomitant Pancreatic Ductal Adenocarcinoma.

Home
Genetic Assessment Of Intraductal Papillary Mucinous Neoplasm For Predicting Concomitant Pancreatic Ductal Adenocarcinoma.

Related Experiment Video

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Genetic Assessment of Intraductal Papillary Mucinous Neoplasm for Predicting Concomitant Pancreatic Ductal

Hideyuki Oi¹, Yuto Hozaka¹, Toshiaki Akahane²

¹From the Departments of Digestive Surgery.

|May 14, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Krüppel-like factor 4 (KLF4) mutations are more frequent in specific pancreatic cysts (IPMNs) that develop into pancreatic ductal adenocarcinoma (PDAC). Genetic assessment may aid in predicting PDAC risk in these IPMNs.

More Related Videos

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Published on: September 28, 2019

Related Experiment Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Technical Detail for Robot Assisted Pancreaticoduodenectomy

Published on: September 28, 2019

Area of Science:

Gastroenterology
Oncology
Molecular Biology

Background:

Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic cystic lesions with malignant potential.
The role of Krüppel-like transcription factor 4 (KLF4) mutations in IPMNs that coexist with pancreatic ductal adenocarcinoma (PDAC) is not well understood.

Purpose of the Study:

To determine the frequency and impact of KLF4 mutations in IPMNs associated with PDAC.
To evaluate KLF4 mutations as a potential biomarker for predicting PDAC development in specific IPMN subtypes.

Main Methods:

DNA analysis of 65 IPMN samples (52 patients), including 13 with concomitant PDAC.
Next-generation sequencing and targeted sequencing for KLF4, GNAS, and KRAS mutations.

Main Results:

KLF4 mutations were detected in 11 of 52 IPMNs.
KLF4 mutations were significantly more frequent in nonintestinal, noninvasive, branch-duct IPMNs, which were the only type to develop concomitant PDAC.
In this IPMN subtype, KLF4 mutations showed 63% sensitivity, 82% specificity, and 79% accuracy for PDAC prediction.

Conclusions:

Genetic assessment, particularly for KLF4 mutations, may assist in identifying patients with specific IPMNs at higher risk for developing PDAC.
Further prospective studies with larger cohorts are necessary to validate these findings.